메뉴 건너뛰기




Volumn 63, Issue 2, 2004, Pages 385-387

Deterioration of the auditory brainstem response in children with type 3 Gaucher disease

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHILD; CLINICAL ARTICLE; DISEASE COURSE; DRUG MEGADOSE; ENZYME DEFICIENCY; ENZYME REPLACEMENT; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; GAUCHER DISEASE; GENOTYPE; HUMAN; MALE; PRIORITY JOURNAL; PURE TONE AUDIOMETRY;

EID: 3242790843     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000130191.31669.48     Document Type: Article
Times cited : (34)

References (9)
  • 1
  • 2
    • 0034880737 scopus 로고    scopus 로고
    • Abnormalities in children with Gaucher disease type 3
    • Bamiou DE, Campbell P, Liasis A, et al. Abnormalities in children with Gaucher disease type 3. Neuropediatrics 2001;32:136-141.
    • (2001) Neuropediatrics , vol.32 , pp. 136-141
    • Bamiou, D.E.1    Campbell, P.2    Liasis, A.3
  • 4
    • 0025236339 scopus 로고
    • Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease
    • Barton NW, Furbish FS, Murray GJ, Garfield M, Brady RO. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc Natl Acad Sci USA 1990;87:1913-1916.
    • (1990) Proc Natl Acad Sci USA , vol.87 , pp. 1913-1916
    • Barton, N.W.1    Furbish, F.S.2    Murray, G.J.3    Garfield, M.4    Brady, R.O.5
  • 5
    • 0035049241 scopus 로고    scopus 로고
    • The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease
    • Altarescu G, Hill S, Wiggs E, et al, The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease. J Pediatr 2001;138:539-547.
    • (2001) J Pediatr , vol.138 , pp. 539-547
    • Altarescu, G.1    Hill, S.2    Wiggs, E.3
  • 6
    • 0035162916 scopus 로고    scopus 로고
    • Improvement of neurological symptoms by enzyme replacement therapy for Gaucher disease type IIIb
    • Aoki M, Takahashi Y, Miwa Y, et al. Improvement of neurological symptoms by enzyme replacement therapy for Gaucher disease type IIIb. Eur J Pediatr 2001;160:63-64.
    • (2001) Eur J Pediatr , vol.160 , pp. 63-64
    • Aoki, M.1    Takahashi, Y.2    Miwa, Y.3
  • 7
    • 0030772366 scopus 로고    scopus 로고
    • Prospective study of neurological responses to treatment with macrophage targeted glucocerebrosidase in patients with type 3 Gaucher disease
    • Schiffman R, Heyes MP, Aerts JM, et al. Prospective study of neurological responses to treatment with macrophage targeted glucocerebrosidase in patients with type 3 Gaucher disease. Ann Neurol 1997;42:613-621.
    • (1997) Ann Neurol , vol.42 , pp. 613-621
    • Schiffman, R.1    Heyes, M.P.2    Aerts, J.M.3
  • 8
    • 0020508736 scopus 로고
    • Non-infantile neuronopathic Gaucher's disease: A clinicopathologic study
    • Winkelman MD, Banker BQ, Victor M, Moser HW. Non-infantile neuronopathic Gaucher's disease: a clinicopathologic study. Neurology 1983; 33:994-1008.
    • (1983) Neurology , vol.33 , pp. 994-1008
    • Winkelman, M.D.1    Banker, B.Q.2    Victor, M.3    Moser, H.W.4
  • 9
    • 0025833151 scopus 로고
    • Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: Neuropathological and neurochemical findings
    • Conradi N, Kyllerman M, Mansson JE, et al. Late-infantile Gaucher disease in a child with myoclonus and bulbar signs: neuropathological and neurochemical findings. Acta Neuropathol (Berl) 1991;82:152-157.
    • (1991) Acta Neuropathol (Berl) , vol.82 , pp. 152-157
    • Conradi, N.1    Kyllerman, M.2    Mansson, J.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.